Infosys Limited
NYSE:INFYInformation Technology Services
-$1.10 today
- Market cap
- $48.98B
- Beta
- 0.11
- P/E (TTM)
- 14.4
- EPS (TTM)
- $0.83
- Dividend yield
- 4.26%
Volume 10.92M
Average 17.93M
Big Five Numbers
Infosys Limited growth analysis
Start with the long-run numbers that show whether INFY compounds: return on capital and growth in sales, earnings, equity, and free cash flow.
Big Five Numbers
CAGR by period · ROIC shows average
| Metric | 10yr | 5yr | 3yr | 1yr |
|---|---|---|---|---|
EPS | N/A | N/A | +5.3% | +9.2% |
Revenue | N/A | N/A | +3.4% | +4.6% |
Equity | N/A | N/A | +3.7% | -9.4% |
Cash | N/A | N/A | +16.5% | -18.2% |
ROIC | N/A | 24.6% | 24.2% | 26.7% |
Analysis
Latest growth is strongest in ROIC at 26.7% and weakest in Cash at -18.2%. Three-year average ROIC is 24.2%, which helps show whether that growth is being earned efficiently.
Growth analysis
Is growth accelerating or fading?
Compare historical growth with analyst forecasts across revenue, earnings, and cash flow.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | +5.3% | +2.4% (4yr)14 analysts |
| Revenue | N/A | N/A | +3.4% | +4.0% (4yr)20 analysts |
| Net Income | N/A | N/A | +3.6% | +2.4% (4yr)20 analysts |
| EBIT | N/A | N/A | +2.2% | +5.6% (4yr)20 analysts |
Analysis
Recent growth has been strongest in EPS at +5.3% over three years. Forward estimates point to EBIT at +5.6% (4yr), giving you a quick check on whether expectations are accelerating or cooling.
Revenue segments
Where does the growth come from?
Break revenue down by product and geography to see which parts of the business drive the trend.
Revenue by segment
Where INFY earns its revenue, as reported in company filings
- Software Services
- Software Products And Platforms
- Software Products
| Segment · FY2026 | Revenue | Share | YoY |
|---|---|---|---|
| Software Services | $19.2B | 95.2% | +4.4% |
| Software Products And Platforms | $962M | 4.8% | +7.1% |
Figures in USD.
Free cash flow
Does growth turn into cash?
Check whether reported growth converts into free cash flow after capital spending.
Free Cash Flow
Net Income to FCF bridge
Analysis
Analysis will appear once cash flow data is available for this period.
Price targets
What do analysts expect from the price?
Compare the current price with the low, average, and high analyst targets.
Wall Street price targets
1-year price history with analyst consensus target
Unlock analyst target range
Sign in free to see low, average, high targets and implied upside for INFY.
Analyst ratings
How do analysts rate the stock?
Review the buy, hold, and sell split and recent upgrades and downgrades.
Analyst ratings
Buy, hold, and sell recommendations and recent rating changes
Unlock analyst ratings
Sign in free to see the buy/hold/sell breakdown and recent rating changes for INFY.
Competitor growth
How does Infosys Limited grow against peers?
Compare historical and forecast growth with similar companies.
Competitor Growth
Peer CAGR comparison & forward estimates
| Company | Market Cap | 10yr | 5yr | 3yr | Fwd |
|---|---|---|---|---|---|
International Business Machines Corporation IBM | $233.57B | -1.9% | +4.1% | +3.7% | +4.3% (5yr)7 analysts |
Accenture plc ACN | $148.05B | +7.9% | +8.0% | +5.0% | +7.4% (4yr)14 analysts |
Cognizant Technology Solutions Corporation CTSH | $28.17B | +5.4% | +4.9% | +2.8% | +4.0% (4yr)11 analysts |
Wipro Limited WIT | $20.97B | +6.1% | +8.4% | +0.8% | +5.9% (4yr)10 analysts |
CGI Inc. GIB | $14.75B | +4.5% | +6.4% | +5.1% | +2.2% (3yr)4 analysts |
ExlService Holdings, Inc. EXLS | $6.52B | +12.8% | +16.8% | +13.9% | +13.5% (3yr)7 analysts |
Globant S.A. GLOB | $1.96B | +25.5% | +24.7% | +11.3% | +6.6% (4yr)11 analysts |
Questions
Growth questions
Common questions about INFY's growth, answered from reported and forecast figures.
Is INFY growing revenue?
Revenue grew 4.6% year over year, from $19.28B to $20.16B.
Is INFY turning growth into profit?
The latest net margin is 16.4%, which shows how much revenue became net income.
Continue the stock analysis
Jump to another research area for this company.